Longevity Services & Practice Library
Every article, presentation, spotlight, and news item we've tagged to Longevity Services & Practice.
Showing 49–72 of 245
Singapore convenes clinical longevity leaders
The NUS Geromedicine Conference (February 2026) addresses the translation gap between geroscience mechanisms and clinical application, bringing together researchers, clinicians, and industry to move from pathway discovery to actionable protocols in real-world longevity practice.
Physician-Led Diagnostic Protocols Drive Integrated Wellness Expansion
Serotonin Centers opened a Del Mar location offering hormone optimization, peptide therapy, IV therapy, hyperbaric oxygen therapy, and advanced diagnostics under physician oversight. This represents a commercial expansion of medically supervised wellness services in response to documented consumer demand for integrated longevity protocols.
Human Longevity launches personal AI‑powered longevity app
Human Longevity has released an AI-powered mobile app that analyzes biometric, lifestyle, and genetic data to generate personalized health recommendations across nutrition, exercise, sleep, and preventive care. The platform's utility depends on the quality of data interpretation and user adherence to recommendations over time.
Agentis, Ultrahuman tie wearables to longevity care
Agentis Longevity and Ultrahuman have partnered to integrate continuous biosensor data with clinical longevity tracking through the Longevity Quotient (LQ) score, creating real-time health monitoring between clinic visits. The collaboration addresses a critical gap in preventive care: translating isolated health data into actionable patterns that reflect actual lifestyle and physiological changes.
‘Our mission is to bring longevity to everyone’
Ambr's explainable AI platform integrates clinical data, biomarkers, and lifestyle information to help primary care physicians identify patient health trajectories and intervene with preventive strategies before disease develops. The approach targets population-level prevention through existing healthcare infrastructure rather than direct-to-consumer channels, addressing the gap between longevity science and routine clinical practice.
Fountain Life adds APEX to premium longevity program
Fountain Life launched APEX, a year-long premium membership that integrates full-body diagnostic screening with functional movement assessment and VO₂ max testing to shift from episodic health snapshots to continuous, performance-focused monitoring. This model addresses a gap in longevity medicine: most preventive programs measure biomarkers and imaging but neglect movement quality and cardiorespiratory capacity—the actual mechanics of aging and functional independence.
CMS, FDA Set Aging Biomarker Requirements for Longevity Coverage
The first major US longevity policy summit convened federal regulators, researchers, and lawmakers to address the regulatory and funding barriers slowing longevity science translation. The convergence signals political recognition that healthspan improvement represents a national priority rather than a niche scientific interest.
Vitalist Bay 2026 Returns to Berkeley May 14–17
Vitalist Bay 2026, the world's largest longevity conference, returns to Berkeley May 14–17 with over 60 speakers and workshops spanning aging biology, AI, biotech translation, and investment. The event consolidates leading researchers, entrepreneurs, clinicians, and investors into a four-day intensive focused on accelerating the scientific and commercial infrastructure around human lifespan extension.
Education platform targets longevity knowledge gap
A curated education marketplace has launched to address the fragmentation in longevity learning, creating a vetted platform for clinicians, practitioners, and consumers to access high-quality programs that bridge scientific discovery and clinical practice. The platform recognizes that rapid advancement in longevity science has outpaced the development of standardized, accessible training infrastructure.
Longevity Show launches 2026 pitch competition
The Longevity Show launches a 2026 pitch competition for consumer-ready healthspan startups, targeting the critical gap between laboratory discovery and real-world implementation. The competition emphasizes clinical plausibility and measurable impact over marketing hype, reflecting the sector's maturation toward systems-based, scalable prevention rather than isolated interventions.
Abu Dhabi opens a real-world test lab for longevity
Abu Dhabi is establishing an integrated health infrastructure that combines clinical records, genetic data, and continuous wearable monitoring into a real-time evidence system designed to shift healthcare from reactive treatment to predictive intervention. This represents a systematic approach to testing longevity interventions within functioning health systems rather than isolated research environments.
Longevity Sector Shifts to Systems-Based Healthspan Infrastructure
Five finalists selected for The Longevity Show's inaugural pitch competition represent a conceptual shift in the longevity sector—from single-intervention therapies to integrated systems spanning therapeutics, nutrition, microbiome science, and healthcare access. The cohort signals movement toward infrastructure that supports healthspan across diverse populations and geographies.
A Multidomain Lifestyle Intervention Is Associated With Improved Functional Trajectories and Favorable Changes in Epigenetic Aging Markers in Frail Older Adults: A Randomized Controlled Trial
A 6-month multidomain lifestyle intervention combining nutritional support and supervised exercise slowed epigenetic aging markers and improved physical function in frail adults over 80, with measurable reductions in biological aging indicators. The findings suggest that coordinated lifestyle strategies can alter the trajectory of age-related decline at the molecular level, not merely at the symptomatic level.
Longevity law finds its footing
As longevity ventures mature from research-driven enterprises to scalable commercial platforms, specialized legal frameworks become essential infrastructure. The establishment of dedicated longevity legal practices signals that regulatory clarity and compliant business model design are now rate-limiting factors for sector growth, not biology itself.
Longevity Show Expands to New York: Bridging Science and Practice
The Longevity Show, a science-focused conference that attracted 3,000+ visitors to London in its inaugural event, will expand to New York in May 2027. The event bridges academic research, clinical practice, and consumer health engagement without compromising scientific rigor—a structural shift that reflects growing mainstream acceptance of longevity science as evidence-based practice rather than wellness marketing.
#383 ‒ AMA #81: Biological aging tests, longevity training, emerging therapies, GLP-1 RAs, sun exposure, and more
This AMA addresses multiple longevity domains: biological aging biomarkers, exercise protocols for longevity, emerging therapeutic approaches, GLP-1 receptor agonists, and sun exposure risk-benefit profiles. The discussion emphasizes that evidence-based interpretation of these tools requires distinguishing between mechanistic plausibility and demonstrated clinical outcomes.
Longevity market poised for growth as AI and genomics accelerate developments
The global longevity market is projected to exceed $740 billion by 2026, driven by a structural shift toward integrated healthcare platforms combining AI, genomics, and regenerative medicine. This transition reflects movement from consumer wellness toward clinical prevention and early risk detection supported by institutional stakeholders.
Death prediction app launches ‘AI health concierge’
Death Clock has launched Life Lab, an AI-driven health concierge that integrates blood biomarker analysis with personalized preventive guidance to help users close the gap between their current and optimized projected lifespan. The service aggregates laboratory testing, medical records, and wearable data to identify actionable interventions across four major chronic disease categories.
Longevity.Technology unveils DLT – the intelligence platform for longevity
Longevity.Technology launched DLT, an AI-driven intelligence platform that aggregates data on over 600 longevity biotech companies, clinical assets, intellectual property, and partnerships into a queryable dataset. This addresses a fragmentation problem in longevity research and investment where critical market intelligence has been scattered across multiple sources.
Vitalist Bay 2026 set to spotlight longevity’s next phase
Vitalist Bay 2026 will convene researchers, investors, and founders in Berkeley for a concentrated four-day program emphasizing AI-driven drug discovery, biostasis, and longevity science. The event reflects the field's shift toward computational approaches while highlighting a persistent gap between scientific ambition and clinical validation.
Hospitals confront longevity’s quiet disruption
Hospital systems designed for acute crisis intervention face structural barriers to adopting longevity-focused prevention, requiring fundamental shifts in incentive structures, data integration, and measurement of success. The transition demands more than clinical protocol changes—it requires cultural reorientation toward longitudinal patient stewardship rather than episodic treatment.
The Longevity Show 80% sold out as inaugural gathers pace
The inaugural Longevity Show has reached 80% capacity in its partner floor with weeks remaining, signaling that longevity has transitioned from niche to mainstream market category. The event's broad ecosystem—spanning diagnostics, nutrition, fitness, therapeutics, and recovery—reflects how health optimization is increasingly understood as systemic rather than vertical.
Longevity Day at NFC Summit Lisbon Announces Speaker Lineup
Longevity Day at NFC Summit Lisbon will convene researchers, clinicians, founders, and investors on June 4, 2026, organizing speakers across three thematic tracks: ancestral wisdom, contemporary science, and frontier biotechnology. The event represents a structured approach to advancing longevity science through interdisciplinary dialogue.
Longevity market to hit $67b by 2035 due to rising aging concerns
The global longevity market is projected to grow from $27.61 billion in 2025 to $67.03 billion by 2035, driven by a shift from reactive disease treatment to preventive health monitoring and consumer-directed self-management. This expansion reflects a fundamental change in how aging is approached—not as an inevitable decline to manage, but as a process to optimize through early detection, biological measurement, and strategic intervention.